Ameriprise’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
|
|||||
|
2025
Q1 | $13.4M | Buy |
|
|||||
|
2024
Q4 | $10.3M | Buy |
|
|||||
|
2024
Q3 | $9.4M | Sell |
|
|||||
|
2024
Q2 | $8.43M | Sell |
|
|||||
|
2024
Q1 | $8.5M | Buy |
|
|||||
|
2023
Q4 | $7.61M | Sell |
|
|||||
|
2023
Q3 | $8.12M | Sell |
|
|||||
|
2023
Q2 | $10.5M | Buy |
|
|||||
|
2023
Q1 | $9.75M | Sell |
|
|||||
|
2022
Q4 | $9.02M | Sell |
|
|||||
|
2022
Q3 | $12.4M | Sell |
|
|||||
|
2022
Q2 | $13.4M | Buy |
|
|||||
|
2022
Q1 | $12.5M | Sell |
|
|||||
|
2021
Q4 | $17.3M | Buy |
|
|||||
|
2021
Q3 | $15.4M | Buy |
|
|||||
|
2021
Q2 | $12M | Sell |
|
|||||
|
2021
Q1 | $14.1M | Sell |
|
|||||
|
2020
Q4 | $16.7M | Sell |
|
|||||
|
2020
Q3 | $19.7M | Sell |
|
|||||
|
2020
Q2 | $51.1M | Buy |
|
|||||
|
2020
Q1 | $24.1M | Buy |
|
|||||
|
2019
Q4 | $32.1M | Sell |
|
|||||
|
2019
Q3 | $33M | Buy |
|
|||||
|
2019
Q2 | $35.6M | Sell |
|
|||||
|
2019
Q1 | $41.6M | Sell |
|
|||||
|
2018
Q4 | $93.1M | Buy |
|
|||||
|
2018
Q3 | $177M | Sell |
|
|||||
|
2018
Q2 | $159M | Sell |
|
|||||
|
2018
Q1 | $128M | Buy |
|
|||||
|
2017
Q4 | $55.8M | Buy |
|
|||||
|
2017
Q3 | $52.3M | Buy |
|
|||||
|
2017
Q2 | $43M | Sell |
|
|||||
|
2017
Q1 | $37.8M | Sell |
|
|||||
|
2016
Q4 | $42.5M | Sell |
|
|||||
|
2016
Q3 | $44M | Buy |
|
|||||
|
2016
Q2 | $48.4M | Buy |
|
|||||
|
2016
Q1 | $41.7M | Buy |
|
|||||
|
2015
Q4 | $35.1M | Buy |
|
|||||
|
2015
Q3 | $27.5M | Sell |
|
|||||
|
2015
Q2 | $35.1M | Buy |
|
|||||
|
2015
Q1 | $25.6M | Buy |
|
|||||
|
2014
Q4 | $6.8M | Buy |
|
|||||
|
2014
Q3 | $5.81M | Sell |
|
|||||
|
2014
Q2 | $9.12M | Buy |
|
|||||
|
2014
Q1 | $7.91M | Buy |
|
|||||
|
2013
Q4 | $5.3M | Buy |
|
|||||
|
2013
Q3 | $1.04M | Sell |
|
|||||
|
2013
Q2 | $2.03M | Buy |
|